DK160501C - Substituerede benzoatestere af 3-hydroxymorphinaner samt farmaceutiske praeparater indeholdende saadanne - Google Patents

Substituerede benzoatestere af 3-hydroxymorphinaner samt farmaceutiske praeparater indeholdende saadanne

Info

Publication number
DK160501C
DK160501C DK306885A DK306885A DK160501C DK 160501 C DK160501 C DK 160501C DK 306885 A DK306885 A DK 306885A DK 306885 A DK306885 A DK 306885A DK 160501 C DK160501 C DK 160501C
Authority
DK
Denmark
Prior art keywords
hydroxymorphinanes
testers
sugar
pharmaceutical preparations
preparations containing
Prior art date
Application number
DK306885A
Other languages
Danish (da)
English (en)
Other versions
DK160501B (da
DK306885A (da
DK306885D0 (da
Inventor
Elie Gabriel Shami
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK306885D0 publication Critical patent/DK306885D0/da
Publication of DK306885A publication Critical patent/DK306885A/da
Publication of DK160501B publication Critical patent/DK160501B/da
Application granted granted Critical
Publication of DK160501C publication Critical patent/DK160501C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08Oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/28Morphinans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK306885A 1984-07-05 1985-07-04 Substituerede benzoatestere af 3-hydroxymorphinaner samt farmaceutiske praeparater indeholdende saadanne DK160501C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62792384A 1984-07-05 1984-07-05
US62792384 1984-07-05
US06/733,464 US4668685A (en) 1984-07-05 1985-05-14 Substituted benzoate ester prodrug derivatives of 3-hydroxymorphinans, which are analgesics or narcotic antagonists
US73346485 1985-05-14

Publications (4)

Publication Number Publication Date
DK306885D0 DK306885D0 (da) 1985-07-04
DK306885A DK306885A (da) 1986-01-06
DK160501B DK160501B (da) 1991-03-18
DK160501C true DK160501C (da) 1991-08-26

Family

ID=27090564

Family Applications (1)

Application Number Title Priority Date Filing Date
DK306885A DK160501C (da) 1984-07-05 1985-07-04 Substituerede benzoatestere af 3-hydroxymorphinaner samt farmaceutiske praeparater indeholdende saadanne

Country Status (18)

Country Link
US (1) US4668685A (OSRAM)
EP (1) EP0170090B1 (OSRAM)
AU (1) AU578391B2 (OSRAM)
CA (1) CA1301150C (OSRAM)
DE (1) DE3573251D1 (OSRAM)
DK (1) DK160501C (OSRAM)
ES (1) ES8704443A1 (OSRAM)
FI (1) FI83215C (OSRAM)
GR (1) GR851653B (OSRAM)
HK (1) HK39790A (OSRAM)
HU (1) HU193995B (OSRAM)
IE (1) IE58136B1 (OSRAM)
IL (1) IL75721A (OSRAM)
MX (1) MX160445A (OSRAM)
NO (1) NO171209C (OSRAM)
NZ (1) NZ212641A (OSRAM)
PT (1) PT80773B (OSRAM)
SU (2) SU1450742A3 (OSRAM)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673679A (en) * 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
DK107688D0 (da) * 1988-03-01 1988-03-01 Novo Industri As Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
US6702705B1 (en) 1988-05-04 2004-03-09 Igen International, Inc. Prodrugs activated by targeted catalytic proteins
DK24089D0 (da) * 1989-01-20 1989-01-20 Hans Bundgaard Novel prodrug derivatives of biologically active agents containing hydroxyl groups or nh-acidic groups
US6258360B1 (en) * 1989-05-04 2001-07-10 Igen International, Inc. Prodrugs activated by targeted catalytic proteins
EP0746336A1 (en) * 1991-08-05 1996-12-11 Igen, Inc. Prodrugs activated by targeted catalytic proteins
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
AU666702B2 (en) * 1992-01-23 1996-02-22 Toray Industries, Inc. Morphinan derivative and medicinal use
TW372972B (en) * 1992-10-23 1999-11-01 Novartis Ag Antiretroviral acyl compounds
DE69427551T2 (de) * 1993-03-15 2002-05-16 National Science Council, Taipeh/T'ai-Pei Nalbuphinester und diese enthaltende Arzneimittel mit verzögerter Wirkstoffabgabe
NZ268969A (en) * 1993-07-23 1997-06-24 Toray Industries Morphinan derivatives and pharmaceutical compositions
US5376662A (en) * 1993-12-08 1994-12-27 Ockert; David M. Method of attenuating nerve injury induced pain
US5869669A (en) * 1996-07-26 1999-02-09 Penick Corporation Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates
US6225321B1 (en) * 1997-06-05 2001-05-01 Oliver Yoa-Pu Hu Long analgesic acting nalbuphine polyester derivative and method of use
KR100417489B1 (ko) 1997-12-22 2004-02-05 유로-셀티크 소시에떼 아노뉨 오피오이드 효능제/길항제 혼합물
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
ES2188481T3 (es) * 2000-04-27 2003-07-01 Oliver Yoa-Pu Hu Derivados de polinalbufina.
US6569449B1 (en) 2000-11-13 2003-05-27 University Of Kentucky Research Foundation Transdermal delivery of opioid antagonist prodrugs
US20030065002A1 (en) 2001-05-11 2003-04-03 Endo Pharmaceuticals, Inc. Abuse-resistant controlled-release opioid dosage form
HRP20040161A2 (en) * 2001-08-23 2004-06-30 Akzo Nobel Nv Process for the preparation of a 14-hydroxynormorphinone derivative
US20040033253A1 (en) * 2002-02-19 2004-02-19 Ihor Shevchuk Acyl opioid antagonists
IL163990A0 (en) 2002-04-05 2005-12-18 Euro Celtique Sa Pharmaceutical preparation containing oxycodone and naloxone
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US20080020028A1 (en) * 2003-08-20 2008-01-24 Euro-Celtique S.A. Transdermal dosage form comprising an active agent and a salt and a free-base form of an adverse agent
EP1604667A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the restless leg syndrome
EP1604666A1 (en) * 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
US20080045610A1 (en) * 2004-09-23 2008-02-21 Alexander Michalow Methods for regulating neurotransmitter systems by inducing counteradaptations
CN101065014A (zh) * 2004-09-23 2007-10-31 亚历山大·米哈洛 通过诱导逆适应调节神经递质系统的方法
CN101132772B (zh) * 2005-01-28 2012-05-09 欧洲凯尔特公司 耐醇剂型
EP1702558A1 (en) * 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
EP1695700A1 (en) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Dosage form containing oxycodone and naloxone
WO2006126529A1 (ja) * 2005-05-25 2006-11-30 Shionogi & Co., Ltd. 6,7-不飽和-7-カルバモイル置換モルヒナン誘導体
WO2007022535A2 (en) 2005-08-19 2007-02-22 Pharmacofore, Inc. Prodrugs of active agents
GB0606124D0 (en) * 2006-03-28 2006-05-03 Reckitt Benckiser Healthcare Buprenorphine derivatives and uses thereof
CA2679973C (en) * 2007-03-09 2012-07-17 Green Cross Corporation Orally bioavailable prodrugs of (+)-3-hydroxymorphinan for parkinson's disease prevention or treatment
CA2730211C (en) * 2008-07-07 2016-11-08 Euro-Celtique S.A. Use of opioid antagonists for treating urinary retention
MX347106B (es) 2009-03-10 2017-04-12 Euro-Celtique S A * Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
US10849981B2 (en) 2009-07-02 2020-12-01 KemPham, Inc. Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
UA102916C2 (uk) 2009-07-02 2013-08-27 Кемфарм, Інк. Композиція на основі кон'югату гідрокодону з бензойною кислотою, похідними бензойної кислоти або гетероарилкарбоновою кислотою, проліки, спосіб лікування від зловживань
WO2011008636A1 (en) * 2009-07-15 2011-01-20 Mallinckrodt Inc. 3-oxy-hydromorphone derivatives
RU2607084C2 (ru) * 2010-11-12 2017-01-10 Сионоги Энд Ко., Лтд. Кристаллы производных 6,7-ненасыщенного-7-карбамоилморфинана и способ их получения
RU2573388C2 (ru) * 2011-10-26 2016-01-20 Кемфарм Инк. Бензойная кислота, производные бензойной кислоты и конъюгаты гетероарилкарбоновой кислоты с гидроморфоном, пролекарства, способы получения и их применение
UA116567C2 (uk) 2013-07-23 2018-04-10 Євро-Селтік С.А. Комбінація оксикодону та налоксону для застосування в лікуванні болю у пацієнтів, які страждають від болю та захворювання, що призводить до дисбактеріозу кишечнику та/або підвищує ризик кишкової бактеріальної транслокації
CN106999486A (zh) 2014-11-25 2017-08-01 凯姆制药公司 羟考酮的苯甲酸缀合物、苯甲酸衍生物缀合物和杂芳基羧酸缀合物
SG11201704309YA (en) 2014-12-02 2017-06-29 Kempharm Inc Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxymorphone, prodrugs, methods and making and use thereof
US10155771B2 (en) * 2015-11-04 2018-12-18 Noramco, Inc. Selective reduction of morphinan alkaloids
WO2020012245A1 (en) 2018-07-13 2020-01-16 Alkermes Pharma Ireland Limited Thienothiophene-naltrexone prodrugs for long-acting injectable compositions
WO2020012248A1 (en) 2018-07-13 2020-01-16 Alkermes Pharma Ireland Limited Novel naphthylenyl compounds for long-acting injectable compositions and related methods
US11186585B2 (en) 2018-08-17 2021-11-30 Kappa-Pharma LLC Compositions and methods of enhancing opioid receptor engagement by opioid hexadienoates and optionally substituted hexadienoates
US10975099B2 (en) 2018-11-05 2021-04-13 Alkermes Pharma Ireland Limited Thiophene compounds for long-acting injectable compositions and related methods
MX2022001520A (es) 2019-08-11 2022-07-21 Kappa Pharma Llc Composiciones y metodos para mejorar activacion de receptor de opioide por hexadienoatos opioides y hexadienoatos opcionalmente sustituidos.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE224197C (OSRAM) *
US3254088A (en) * 1961-03-14 1966-05-31 Lewenstein Morphine derivative
FR1602610A (en) * 1962-10-10 1971-01-04 10.10.62.-17.4.63. 38445-15209 thebaine derivs
US3332950A (en) * 1963-03-23 1967-07-25 Endo Lab 14-hydroxydihydronormorphinone derivatives
IL26896A (en) * 1966-01-19 1970-11-30 Endo Lab 14 - Hydroxynormorphinins and 14 - Hydroxynormorphinones
GB1097167A (en) * 1966-05-31 1967-12-29 Shionogi & Co 3-hydroxy-6-oxo-n-phenethylmorphinan compounds and their production
CH543514A (de) * 1967-08-25 1973-10-31 Hoffmann La Roche Verfahren zur Herstellung von Morphinanderivaten
US3654280A (en) * 1968-03-21 1972-04-04 Shionogi & Co L-n allylic-3-hydroxy-6-oxomorphinans
DE2323192A1 (de) * 1972-05-10 1973-12-13 Endo Lab Injizierbare, langwirkende antagonistpraeparate gegen narkotika und rauschgifte
US4161597A (en) * 1976-12-20 1979-07-17 Research Corporation N-alkyl-14-hydroxymorphinans and derivatives
JPS59184183A (ja) * 1983-04-02 1984-10-19 Res Inst For Prod Dev 3−ベンゾイルチオ−4、5α−エポキシ−7α−〔1(R)−ヒドロキシ−1−メチルブチル〕−6−メトキシ−17−メチル−6、14−エンド−エテノモルヒナン
JPS59184182A (ja) * 1983-04-02 1984-10-19 Res Inst For Prod Dev 3−ベンゾイルチオ−4、5α−エポキシ−7α−〔1(R)−ヒドロキシ−1−メチルベンチル〕−6−メトキシ−17−メチル−6、14−エンド−エタノモルヒナン
JPS59184163A (ja) * 1983-04-02 1984-10-19 Res Inst For Prod Dev 3−ベンゾイルチオ−17−メチルモルヒナン
JPS59186987A (ja) * 1983-04-06 1984-10-23 Res Inst For Prod Dev 3−ベンゾイルチオ−4、5α−エポキシ−7α−〔1(R)−ヒドロキシ−1−メチルブチル〕−6−メトキシ−17−メチル−6、14−エンド−エテノモルヒナン

Also Published As

Publication number Publication date
FI83215B (fi) 1991-02-28
EP0170090B1 (en) 1989-09-27
SU1450742A3 (ru) 1989-01-07
DK160501B (da) 1991-03-18
ES544852A0 (es) 1987-04-01
DE3573251D1 (en) 1989-11-02
NO852699L (no) 1986-01-06
PT80773B (pt) 1987-10-20
HK39790A (en) 1990-06-01
GR851653B (OSRAM) 1985-11-26
AU4451685A (en) 1986-01-09
SU1508960A3 (ru) 1989-09-15
MX160445A (es) 1990-03-02
EP0170090A1 (en) 1986-02-05
ES8704443A1 (es) 1987-04-01
NZ212641A (en) 1988-10-28
FI852659A0 (fi) 1985-07-04
IE851683L (en) 1986-01-05
IL75721A0 (en) 1985-11-29
NO171209B (no) 1992-11-02
DK306885A (da) 1986-01-06
IE58136B1 (en) 1993-07-14
FI83215C (fi) 1991-06-10
PT80773A (en) 1985-08-01
DK306885D0 (da) 1985-07-04
HU193995B (en) 1987-12-28
AU578391B2 (en) 1988-10-20
HUT40132A (en) 1986-11-28
NO171209C (no) 1993-02-10
CA1301150C (en) 1992-05-19
IL75721A (en) 1990-04-29
FI852659L (fi) 1986-01-06
US4668685A (en) 1987-05-26

Similar Documents

Publication Publication Date Title
DK160501C (da) Substituerede benzoatestere af 3-hydroxymorphinaner samt farmaceutiske praeparater indeholdende saadanne
DK154085D0 (da) N-aryl-n-(4-piperidinyl)-amider samt farmaceutiske praeparater deraf
DK164564C (da) Pakdaasetaetning samt anvendelse af denne
DK312386D0 (da) N-aralkyl-piperidenmethanolderivater samt disses fremstilling
DK164851C (da) N-phenylmethylenalkadienamider med analgetisk virkning samt farmaceutiske praeparater indeholdende samme
DK245087A (da) Triazolderivater samt herbicid indeholdende et saadant
DK164852C (da) N-phenylmethylenalkanamider med analgetisk virkning samt farmaceutiske praeparater indeholdende samme
MX9203126A (es) Derivados de sulfonilurea y composiciones farmaceuticas que los contienen.
DK430285A (da) N-substituerede derivater af 2-(pyridylalkensulfinyl)-benzimidazoler samt disses fremstilling
DK237187D0 (da) Farmaceutisk anvendelse af t-pa
ES296415Y (es) Reloj de agujas horaria y minutera de configuracion diferente
DK166355C (da) Adenosin-derivater samt farmaceutiske praeparater indeholdende saadanne derivater
DK537685A (da) Fremgangsmaade til fremstilling af isosilybinfrit silibinin samt laegemiddel med indhold deraf
DK497685D0 (da) Ketongruppeholdige oxindol-3-carboxamid-derivater og laegemiddel indeholdende saadanne derivater
DK226787A (da) Acryl-modificeret polyurethanbaseret klaebestof uden indhold af oploesningsmidler samt fremgangsmaade til fremstilling af et saadant klaebestof
DK164149C (da) Fremgangsmaade til fremstilling af et praeparat indeholdende methylhydroxyprogesteronacetat samt farmaceutisk praeparat indeholdende stoffet
NO169339C (no) Derivater av 4-hydroksy-2h-1-benzotiopyran-2-on, samt rottegiftpreparat hvor slike derivater inngaar
DK312485A (da) Benzo(b)thiophen-derivater og farmaceutiske praeparater indeholdende disse
DK205986D0 (da) Proteinhydrolysat samt fremstilling deraf
DK475187A (da) Delta22-derivater af ll-f28249-forbindelser samt anvendelse deraf
DK196885D0 (da) Farmaceutiske praeparater indeholdende isoquinolinderivater og isoquinolinderivater indeholdende saadanne derivater
DK143188D0 (da) Farmaceutiske praeparater indeholdende pyranoquinolinforbindelser samt deres anvendelse
DK162186D0 (da) Aminoketonderivater samt laegemidler indeholdende saadanne derivater
DK115288D0 (da) Pesticid anvendelse af 2-phenylimidazolderivater samt 2-phenyl-imidazolderivater og fremgangsmaader til deres fremstilling
DK69387A (da) Cyanoderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne

Legal Events

Date Code Title Description
PBP Patent lapsed